Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501452PMID: 30000512
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 113662-23-0
Drug Levels and Effects
Summary of Use during Lactation
Gadobenate has been safely used in infants, so it does not appear to pose a substantial risk to a breastfed infant.[1] Guidelines developed by North American professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium.[2-4]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Fraum TJ, Ludwig DR, Bashir MR, et al. Gadolinium-based contrast agents: A comprehensive risk assessment. J Magn Reson Imaging 2017;46:338-53. [PubMed: 28083913]
- 2.
- Copel J, El-Sayed Y, Heine RP, et al. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2017;130:e210-e6. [PubMed: 28937575]
- 3.
- American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2023;Version 2023:120-1. https://www
.acr.org/Clinical-Resources /Contrast-Manual - 4.
- Bookwalter CA, McDonald RJ, Packard AT, et al. Contrast media in pregnant and lactating patients, from the AJR special series on contrast media. AJR Am J Roentgenol 2024. [PubMed: 39046138]
Substance Identification
Substance Name
Gadobenate
CAS Registry Number
113662-23-0
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Gadobenate - Drugs and Lactation Database (LactMed®)Gadobenate - Drugs and Lactation Database (LactMed®)
- gadobenic acid [Supplementary Concept]gadobenic acid [Supplementary Concept]used in MR imaging of liver<br/>Date introduced: January 11, 1989<br/>MeSH
- gadobutrol [Supplementary Concept]gadobutrol [Supplementary Concept]structure in first source<br/>Date introduced: December 26, 1994<br/>MeSH
- Gadobutrol - Drugs and Lactation Database (LactMed®)Gadobutrol - Drugs and Lactation Database (LactMed®)
- GadoliniumGadoliniumAn element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear r...<br/>Date introduced: January 1, 1999<br/>MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...